跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG - HSA Drug Approval Details
Approvals
/
HSA
/
APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG
Approved
THERAPEUTIC
APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG
Apotex Inc.
🇸🇬 Health Sciences Authority
Approval Date
Mar 30, 2016
Approval ID
6acdd43a24ab7ccc
Company
Apotex Inc.
Type
Therapeutic
Approval Details
Approval Id
6acdd43a24ab7ccc
Drug Name
APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG
Product Name
APO-OLANZAPINE ODT ORALLY DISINTEGRATING TABLET 5MG
Approval Number
SIN14974P
Approval Date
2016-03-30
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route Of Administration
ORAL
Atc Code
N05AH03
Atc Item Name
olanzapine
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Company Detail Path
/organization/pharmaforte-singapore-pte-ltd
Active Ingredients
OLANZAPINE
5.0MG
OLANZAPINE
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 30, 2016
Approval ID
6acdd43a24ab7ccc
Type
Therapeutic
Back to HSA Approvals
